X

Trial Profile

Selecitve progesterone receptor modulators for treatment of premenstrual dysphoric disorder. A randomized, double-blind, placebo controlled study.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Dec 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ulipristal (Primary)
Indications Premenstrual dysphoric disorder
Focus Therapeutic Use

Most Recent Events

21 Dec 2020 New trial record
10 Dec 2020 Status changed from recruiting to completed, as per results published in the American Journal of Psychiatry
10 Dec 2020 Primary endpoint (Daily Record of Severity of Problems (DRSP)) has been met, as per results published in the American Journal of Psychiatry

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com